KineMed Report issue

For profit
Founded: Emeryville CA United States (2001)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00596427
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Carine Beysen | KineMed, Inc.

Active Ingredients

Drugs in Other Trials (2)

colesevelam (welchol) (2 trials)

sitagliptin (januvia) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2